A Prospective, Single-center, Open-label Clinical Study to Evaluate the Safety and Efficacy of Inhaled BMD003(CFTR mRNA) in Chinese Adult Patients With Cystic Fibrosis

Clinical trial NCT06963008 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06963008
Sponsor: Peking Union Medical College Hospital
Status: NOT_YET_RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Cystic Fibrosis (CF)Gene Therapy

Start date: 2025-05-10
Primary completion: 2026-05-10
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.